1463 related articles for article (PubMed ID: 20427754)
1. Distinguishing acute-onset CIDP from fluctuating Guillain-Barre syndrome: a prospective study.
Ruts L; Drenthen J; Jacobs BC; van Doorn PA;
Neurology; 2010 May; 74(21):1680-6. PubMed ID: 20427754
[TBL] [Abstract][Full Text] [Related]
2. Distinguishing acute-onset CIDP from Guillain-Barré syndrome with treatment related fluctuations.
Ruts L; van Koningsveld R; van Doorn PA
Neurology; 2005 Jul; 65(1):138-40. PubMed ID: 16009902
[TBL] [Abstract][Full Text] [Related]
3. [Acute-Onset Chronic Inflammatory Demyelinating Polyradiculoneuropathy].
Kanbayashi T; Sonoo M
Brain Nerve; 2015 Nov; 67(11):1388-96. PubMed ID: 26560954
[TBL] [Abstract][Full Text] [Related]
4. Defective Fas-mediated T-cell apoptosis predicts acute onset CIDP.
Comi C; Osio M; Ferretti M; Mesturini R; Cappellano G; Chiocchetti A; Carecchio M; Nascimbene C; Varrasi C; Cantello R; Mariani C; Monaco F; Dianzani U
J Peripher Nerv Syst; 2009 Jun; 14(2):101-6. PubMed ID: 19691532
[TBL] [Abstract][Full Text] [Related]
5. Patients with chronic inflammatory demyelinating polyneuropathy initially diagnosed as Guillain-Barré syndrome.
Odaka M; Yuki N; Hirata K
J Neurol; 2003 Aug; 250(8):913-6. PubMed ID: 12928908
[TBL] [Abstract][Full Text] [Related]
6. Clinical and electrophysiological parameters distinguishing acute-onset chronic inflammatory demyelinating polyneuropathy from acute inflammatory demyelinating polyneuropathy.
Dionne A; Nicolle MW; Hahn AF
Muscle Nerve; 2010 Feb; 41(2):202-7. PubMed ID: 19882646
[TBL] [Abstract][Full Text] [Related]
7. Clinical presentation and course of childhood Guillain-Barré syndrome: a prospective multicentre study.
Korinthenberg R; Schessl J; Kirschner J
Neuropediatrics; 2007 Feb; 38(1):10-7. PubMed ID: 17607598
[TBL] [Abstract][Full Text] [Related]
8. GM1/GalNAc-GD1a complex: a target for pure motor Guillain-Barre syndrome.
Kaida K; Sonoo M; Ogawa G; Kamakura K; Ueda-Sada M; Arita M; Motoyoshi K; Kusunoki S
Neurology; 2008 Nov; 71(21):1683-90. PubMed ID: 19015484
[TBL] [Abstract][Full Text] [Related]
9. Altered cerebrospinal fluid index of prealbumin, fibrinogen, and haptoglobin in patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.
Zhang HL; Zhang XM; Mao XJ; Deng H; Li HF; Press R; Fredrikson S; Zhu J
Acta Neurol Scand; 2012 Feb; 125(2):129-35. PubMed ID: 21434877
[TBL] [Abstract][Full Text] [Related]
10. Clinical variants of Guillain-Barre syndrome: some aspects of differential diagnosis.
Dididze MN
Georgian Med News; 2009 Jan; (166):48-51. PubMed ID: 19202218
[TBL] [Abstract][Full Text] [Related]
11. Electrodiagnostic criteria for acute and chronic inflammatory demyelinating polyradiculoneuropathy.
Van den Bergh PY; Piéret F
Muscle Nerve; 2004 Apr; 29(4):565-74. PubMed ID: 15052622
[TBL] [Abstract][Full Text] [Related]
12. The expression pattern of inflammatory mediators in cerebrospinal fluid differentiates Guillain-Barré syndrome from chronic inflammatory demyelinating polyneuropathy.
Sainaghi PP; Collimedaglia L; Alciato F; Leone MA; Naldi P; Molinari R; Monaco F; Avanzi GC
Cytokine; 2010 Aug; 51(2):138-43. PubMed ID: 20538476
[TBL] [Abstract][Full Text] [Related]
13. Neuromuscular respiratory failure in Guillain-Barre Syndrome: evaluation of clinical and electrodiagnostic predictors.
Sundar U; Abraham E; Gharat A; Yeolekar ME; Trivedi T; Dwivedi N
J Assoc Physicians India; 2005 Sep; 53():764-8. PubMed ID: 16334619
[TBL] [Abstract][Full Text] [Related]
14. The sural sensory nerve is usually spared in Guillain-Barre syndrome.
Wee AS; Abernathy SD
J Miss State Med Assoc; 2003 Aug; 44(8):251-5. PubMed ID: 14531230
[TBL] [Abstract][Full Text] [Related]
15. Dendritic cells in the cerebrospinal fluid and peripheral nerves in Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy.
Press R; Nennesmo I; Kouwenhoven M; Huang YM; Link H; Pashenkov M
J Neuroimmunol; 2005 Feb; 159(1-2):165-76. PubMed ID: 15652416
[TBL] [Abstract][Full Text] [Related]
16. Clinical, electrophysiological subtypes and antiganglioside antibodies in childhood Guillain-Barré syndrome.
Kannan MA; Ch RK; Jabeen SA; Mridula KR; Rao P; Borgohain R
Neurol India; 2011; 59(5):727-32. PubMed ID: 22019659
[TBL] [Abstract][Full Text] [Related]
17. [Recent aspects of acute and chronic inflammatory polyneuropathies: Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy].
Pascual-Pascual SI
Rev Neurol; 2002 Aug 1-15; 35(3):269-76. PubMed ID: 12235589
[TBL] [Abstract][Full Text] [Related]
18. Antibodies to peripheral nerve myelin proteins in chronic inflammatory demyelinating polyradiculoneuropathy.
Allen D; Giannopoulos K; Gray I; Gregson N; Makowska A; Pritchard J; Hughes RA
J Peripher Nerv Syst; 2005 Jun; 10(2):174-80. PubMed ID: 15958128
[TBL] [Abstract][Full Text] [Related]
19. Corticosteroids can help distinguish between Guillain-Barré syndrome and first attack of chronic inflammatory demyelinating neuropathy: an illustrative case report.
Alexander KJ; Alshubaili AF; Santhamoorthy P; Sharafuddin KM
Med Princ Pract; 2008; 17(5):422-4. PubMed ID: 18685286
[TBL] [Abstract][Full Text] [Related]
20. Antibodies to LM1 and LM1-containing ganglioside complexes in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.
Kuwahara M; Suzuki S; Takada K; Kusunoki S
J Neuroimmunol; 2011 Oct; 239(1-2):87-90. PubMed ID: 21914557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]